A Randomized Phase 2 Trial of ASTX727 +/- Iadademstat in Accelerated/Blast-Phase Philadelphia Chromosome-Negative Myeloproliferative Neoplasms (MPNs)
Latest Information Update: 31 Oct 2024
At a glance
- Drugs Cedazuridine/decitabine (Primary) ; Iadademstat
- Indications Essential thrombocythaemia; Myelofibrosis; Myeloproliferative disorders; Polycythaemia vera
- Focus Therapeutic Use
- 31 Oct 2024 New trial record